On Mar 10, 2022 Freeline closed a Post-IPO Equity round and raised $26,100,000 from Syncona Partners LLP, featuring lead investors Syncona Partners LLP.

About the company: Freeline is located at United Kingdom, Europe.
“A leading biotechnology company focused on innovative liver directed gene therapies for bleeding disorders and other debilitating, chronic diseases”

Company website: http://www.freeline.life